Clinical Trial Update: Effect of Clopidogrel (Plavix) on Postoperative Bleeding in Patients Undergoing Coronary Artery Bypass Surgery. [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial assessing the impact of clopidogrel on postoperative bleeding in patients undergoing coronary artery bypass graft surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• CLOPIDOGREL (CLOPIDOGREL)
• Plavix (clopidogrel)

Snippet

Sponsor: Catharina Ziekenhuis Eindhoven | Conditions: Coronary Artery Disease | Phase 4 | Status: COMPLETED